9,217 Shares in Colgate-Palmolive Company $CL Acquired by Little House Capital LLC

Key Points

• Little House Capital LLC acquired 9,217 shares of Colgate-Palmolive Company, valued at approximately $838,000, during the second quarter, highlighting continued interest in the stock by institutional investors.
• Colgate-Palmolive announced a quarterly dividend of $0.52 per share, with a payout ratio of 58.43%, which is significant for income-focused investors.
• Analysts have varied price targets for Colgate-Palmolive, with Citigroup reducing their target from $108.00 to $105.00, indicating some cautious sentiment among market analysts.

Little House Capital LLC bought a new position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 9,217 shares of the company's stock, valued at approximately $838,000.

A number of other institutional investors have also made changes to their positions in CL. Price T Rowe Associates Inc. MD increased its holdings in shares of Colgate-Palmolive by 18.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company's stock worth $3,186,651,000 after acquiring an additional 5,269,140 shares during the last quarter. Nuveen LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $217,593,000. Goldman Sachs Group Inc. increased its holdings in shares of Colgate-Palmolive by 34.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company's stock worth $747,762,000 after acquiring an additional 2,045,191 shares during the last quarter. Diamond Hill Capital Management Inc. increased its holdings in shares of Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company's stock worth $521,250,000 after acquiring an additional 1,727,105 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Colgate-Palmolive by 10,601.7% during the 1st quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company's stock worth $103,574,000 after acquiring an additional 1,095,050 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of research reports. Citigroup decreased their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. Barclays upped their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday, July 15th. JPMorgan Chase & Co. decreased their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Finally, UBS Group decreased their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Stock Performance

CL opened at $82.10 on Tuesday. The firm has a market cap of $66.35 billion, a P/E ratio of 23.06, a price-to-earnings-growth ratio of 4.33 and a beta of 0.35. Colgate-Palmolive Company has a 52-week low of $81.60 and a 52-week high of $105.92. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The business's fifty day moving average is $85.72 and its 200-day moving average is $89.47.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive's quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's dividend payout ratio is 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.